MediWound Ltd.
MDWD
$17.71
-$0.455-2.51%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/28/2025
-
GuruFocus
4/28/2025
-
The Fly
4/28/2025
-
Globe Newswire
4/28/2025
-
ETF Channel
4/27/2025
-
MarketBeat
4/22/2025
-
Tickeron - Stocks
4/19/2025
-
MarketBeat
4/18/2025
-
Tickeron - Technical Analysis
4/18/2025
-
Simply Wall St
4/12/2025
-
Tickeron - Stocks
MediWound (MDWD, $16.37) entered Uptrend as Momentum indicator ascends above 0 level on Apr 11, 2025
4/12/2025
-
Tickeron - Stocks
4/11/2025
-
MarketBeat
4/10/2025
-
Tickeron - Stocks
4/9/2025
-
Tickeron - Technical Analysis
4/7/2025
-
TipRanks Financial Blog
4/4/2025
-
Tickeron - Stocks
3/27/2025
-
ETF Channel
3/25/2025
-
Tickeron - Stocks
3/25/2025
-
Tickeron - Stocks
3/24/2025
-
MarketBeat
3/23/2025
-
MarketBeat
3/22/2025
-
MarketBeat
3/21/2025
-
GuruFocus
3/21/2025
-
MarketBeat
3/21/2025
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Wednesday, March 19, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 26 and 30 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
972 7 797 14100
Address
42 Hayarkon Street
Yavne, 8122745
Yavne, 8122745
Country
Year Founded
Business Description
Sector
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States...
more